SANUWAVE Health (SNWV) Stock Overview
Operates as a medical device company in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
SNWV Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
SANUWAVE Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$14.91 |
| 52 Week High | US$46.59 |
| 52 Week Low | US$14.11 |
| Beta | 1.34 |
| 1 Month Change | -11.51% |
| 3 Month Change | -32.82% |
| 1 Year Change | -49.80% |
| 3 Year Change | 98.80% |
| 5 Year Change | -78.62% |
| Change since IPO | -99.24% |
Recent News & Updates
Shareholders Shouldn’t Be Too Comfortable With SANUWAVE Health's (NASDAQ:SNWV) Strong Earnings
After announcing healthy earnings, SANUWAVE Health, Inc.'s ( NASDAQ:SNWV ) stock rose over the last week. Despite the...
SNWV: Future Upside Will Hinge On Executing 2026 Revenue Plans
Analysts have reduced their price target on SANUWAVE Health by $6 to $43.50, citing updated assumptions around discount rates and future P/E multiples as the key drivers of the change. Analyst Commentary Bullish Takeaways Bullish analysts view the revised price target of $43.50 as still implying meaningful upside from current levels, suggesting the stock screens attractively under their updated P/E framework.SNWV: Future Earnings Power Will Depend On Delivering 2026 Revenue Guidance
Analysts have reduced their price target on SANUWAVE Health by $6 to reflect updated assumptions around discount rate, revenue growth, profit margin and forward P/E. This Narrative Update explains what that change may mean for your thesis on the stock.SNWV: Future Earnings Power Will Depend On Executing Against 2026 Revenue Guidance
Analysts cut their price target on SANUWAVE Health by $6 to reflect updated expectations for revenue growth and profit margins, as well as a higher future P/E multiple. This has led to a revised view of the company’s risk and reward profile.SNWV: Future Earnings Power Will Drive Optimistic View Despite Reset Expectations
Analysts have reduced their price target on SANUWAVE Health from about $55 to about $43.50, citing updated assumptions for revenue growth, profit margins, discount rate, and future price-to-earnings (P/E) expectations. Analyst Commentary Bullish Takeaways Bullish analysts view the new US$43.50 price target as still allowing upside if the company executes on its revenue growth assumptions and maintains the projected profit margin profile.Recent updates
Shareholders Shouldn’t Be Too Comfortable With SANUWAVE Health's (NASDAQ:SNWV) Strong Earnings
After announcing healthy earnings, SANUWAVE Health, Inc.'s ( NASDAQ:SNWV ) stock rose over the last week. Despite the...SNWV: Future Upside Will Hinge On Executing 2026 Revenue Plans
Analysts have reduced their price target on SANUWAVE Health by $6 to $43.50, citing updated assumptions around discount rates and future P/E multiples as the key drivers of the change. Analyst Commentary Bullish Takeaways Bullish analysts view the revised price target of $43.50 as still implying meaningful upside from current levels, suggesting the stock screens attractively under their updated P/E framework.SNWV: Future Earnings Power Will Depend On Delivering 2026 Revenue Guidance
Analysts have reduced their price target on SANUWAVE Health by $6 to reflect updated assumptions around discount rate, revenue growth, profit margin and forward P/E. This Narrative Update explains what that change may mean for your thesis on the stock.SNWV: Future Earnings Power Will Depend On Executing Against 2026 Revenue Guidance
Analysts cut their price target on SANUWAVE Health by $6 to reflect updated expectations for revenue growth and profit margins, as well as a higher future P/E multiple. This has led to a revised view of the company’s risk and reward profile.SNWV: Future Earnings Power Will Drive Optimistic View Despite Reset Expectations
Analysts have reduced their price target on SANUWAVE Health from about $55 to about $43.50, citing updated assumptions for revenue growth, profit margins, discount rate, and future price-to-earnings (P/E) expectations. Analyst Commentary Bullish Takeaways Bullish analysts view the new US$43.50 price target as still allowing upside if the company executes on its revenue growth assumptions and maintains the projected profit margin profile.SANUWAVE Health, Inc. (NASDAQ:SNWV) Stocks Pounded By 25% But Not Lagging Industry On Growth Or Pricing
SANUWAVE Health, Inc. ( NASDAQ:SNWV ) shareholders that were waiting for something to happen have been dealt a blow...Sanuwave: A Long-Term Compounder In Its Early Stages
Summary Sanuwave’s UltraMIST system is gaining significant traction for wound treatment, driven by its razor and razor blade business model. Q2 revenue grew 42% year over year, with full year guidance calling for 50% growth at the midpoint. Q2 gross margin was 78.3% and is expected to gradually increase in the coming quarters due to lower manufacturing costs. Following the anticipated refinancing of its high interest debt, the business should generate strong FCF. I find SNWV stock to be attractively valued at an EV/Revenuemultiple of just 7 and hence assign it a Buy rating. Read the full article on Seeking AlphaRevenues Tell The Story For SANUWAVE Health, Inc. (NASDAQ:SNWV) As Its Stock Soars 28%
SANUWAVE Health, Inc. ( NASDAQ:SNWV ) shares have continued their recent momentum with a 28% gain in the last month...Expanding Sales Force And Marketing Will Drive Wound Care Adoption
Analysts raised their price target for SANUWAVE Health from $49.00 to $54.00 following strong Q2 results, upward revisions to FY25 AEBITDA and continued revenue guidance confidence, reflecting increased conviction in profitability and growth. Analyst Commentary Bullish analysts cited strong Q2 results as a key driver for the price target increase.Expanding Nursing Home And Long Term Care Will Create Opportunities
Expansion in healthcare networks and minimal market penetration enable strong long-term growth opportunities, driven by demographic trends and rising chronic wound cases.Revenues Tell The Story For SANUWAVE Health, Inc. (NASDAQ:SNWV)
SANUWAVE Health, Inc.'s ( NASDAQ:SNWV ) price-to-sales (or "P/S") ratio of 7.8x may look like a poor investment...Why We're Not Concerned About SANUWAVE Health, Inc.'s (NASDAQ:SNWV) Share Price
You may think that with a price-to-sales (or "P/S") ratio of 9.2x SANUWAVE Health, Inc. ( NASDAQ:SNWV ) is a stock to...Shareholder Returns
| SNWV | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.0% | -0.5% | 0.9% |
| 1Y | -49.8% | -20.1% | 24.5% |
Return vs Industry: SNWV underperformed the US Medical Equipment industry which returned -20.2% over the past year.
Return vs Market: SNWV underperformed the US Market which returned 24.2% over the past year.
Price Volatility
| SNWV volatility | |
|---|---|
| SNWV Average Weekly Movement | 9.8% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SNWV has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: SNWV's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 55 | Morgan Frank | sanuwave.com |
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds.
SANUWAVE Health, Inc. Fundamentals Summary
| SNWV fundamental statistics | |
|---|---|
| Market cap | US$128.21m |
| Earnings (TTM) | US$16.49m |
| Revenue (TTM) | US$44.34m |
Is SNWV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNWV income statement (TTM) | |
|---|---|
| Revenue | US$44.34m |
| Cost of Revenue | US$10.31m |
| Gross Profit | US$34.03m |
| Other Expenses | US$17.53m |
| Earnings | US$16.49m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.92 |
| Gross Margin | 76.74% |
| Net Profit Margin | 37.20% |
| Debt/Equity Ratio | 1,119.2% |
How did SNWV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/14 01:10 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SANUWAVE Health, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Carl Byrnes | Northland Capital Markets |
| Kyle Bauser | Roth Capital Partners |